162 related articles for article (PubMed ID: 31720872)
1. Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy.
Rodríguez-Sánchez B; Peña-Longobardo LM; Sinclair AJ
Eur J Health Econ; 2020 Apr; 21(3):335-349. PubMed ID: 31720872
[TBL] [Abstract][Full Text] [Related]
2. [The Neuropad test in the screening of peripheral neuropathy in diabetic patients].
Freitas C; Carvalho A; Melo-Rocha G; Amaral C; Pinto S; Guimarães R; Neto H; Suascun J; Muras J; Gonçalves I; Martins J; Dores J; Carvalho R; Borges F
Acta Med Port; 2009; 22(6):729-34. PubMed ID: 20350454
[TBL] [Abstract][Full Text] [Related]
3. Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer Measurement.
Zografou I; Iliadis F; Sambanis C; Didangelos T
Curr Vasc Pharmacol; 2020; 18(5):517-522. PubMed ID: 31340739
[TBL] [Abstract][Full Text] [Related]
4. [Sudomotor dysfunction diagnostic test for early detection of diabetic neuropathy].
Lorenzini N; Díaz C; Quintana T
Rev Med Chil; 2020 Jan; 148(1):54-59. PubMed ID: 32730436
[TBL] [Abstract][Full Text] [Related]
5. Neuropad for the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes.
Mendivil CO; Kattah W; Orduz A; Tique C; Cárdenas JL; Patiño JE
J Diabetes Complications; 2016; 30(1):93-8. PubMed ID: 26525688
[TBL] [Abstract][Full Text] [Related]
6. Easier operation and similar power of 10 g monofilament test for screening diabetic peripheral neuropathy.
Zhang Q; Yi N; Liu S; Zheng H; Qiao X; Xiong Q; Liu X; Zhang S; Wen J; Ye H; Zhou L; Li Y; Hu R; Lu B
J Int Med Res; 2018 Aug; 46(8):3278-3284. PubMed ID: 29808737
[TBL] [Abstract][Full Text] [Related]
7. A prospective study on the use of the indicator test Neuropad® for the early diagnosis of peripheral neuropathy in type 2 diabetes.
Papanas N; Papatheodorou K; Papazoglou D; Kotsiou S; Maltezos E
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):122-5. PubMed ID: 20690070
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Accuracy of Monofilament Tests for Detecting Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis.
Wang F; Zhang J; Yu J; Liu S; Zhang R; Ma X; Yang Y; Wang P
J Diabetes Res; 2017; 2017():8787261. PubMed ID: 29119118
[TBL] [Abstract][Full Text] [Related]
9. Influence of peripheral arterial occlusive disease on the Neuropad(®) test performance in patients with diabetes.
Aubert CE; Le Doeuff J; Lajou J; Barthelemy O; Hartemann A; Bourron O
Diabet Med; 2013 May; 30(5):e178-84. PubMed ID: 23398465
[TBL] [Abstract][Full Text] [Related]
10. Simple screening tests for peripheral neuropathy in the diabetes clinic.
Perkins BA; Olaleye D; Zinman B; Bril V
Diabetes Care; 2001 Feb; 24(2):250-6. PubMed ID: 11213874
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes: the KORA F4 survey.
Ziegler D; Papanas N; Rathmann W; Heier M; Scheer M; Meisinger C;
Diabetes Metab Res Rev; 2012 Nov; 28(8):692-7. PubMed ID: 22949335
[TBL] [Abstract][Full Text] [Related]
12. Useful application of the Neuropad test for assessment of diabetic polyneuropathy.
Yoshioka K; Okada H
Intern Med; 2012; 51(23):3241-5. PubMed ID: 23207118
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review.
Dros J; Wewerinke A; Bindels PJ; van Weert HC
Ann Fam Med; 2009; 7(6):555-8. PubMed ID: 19901316
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice.
Kamenov ZA; Petrova JJ; Christov VG
Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):226-33. PubMed ID: 20200815
[TBL] [Abstract][Full Text] [Related]
15. [Neuropad test in evaluation of diabetic foot].
Vieru A; Niţă O; Graur LI; Mazilu G; Mihalache L; Popescu RM; Graur M
Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):90-6. PubMed ID: 23077878
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study.
Papanas N; Giassakis G; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Piperidou H; Maltezos E
J Diabetes Complications; 2007; 21(6):353-8. PubMed ID: 17967706
[TBL] [Abstract][Full Text] [Related]
17. An economic evaluation of pregabalin versus usual care in the management of community-treated patients with refractory painful diabetic peripheral neuropathy in primary care settings.
de Salas-Cansado M; Pérez C; Saldaña MT; Navarro A; González-Gómez FJ; Ruiz L; Rejas J
Prim Care Diabetes; 2012 Dec; 6(4):303-12. PubMed ID: 22595032
[TBL] [Abstract][Full Text] [Related]
18. The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy.
Feng Y; Schlösser FJ; Sumpio BE
J Vasc Surg; 2009 Sep; 50(3):675-82, 682.e1. PubMed ID: 19595541
[TBL] [Abstract][Full Text] [Related]
19. A Trial-Based Economic Evaluation Comparing Spinal Cord Stimulation With Best Medical Treatment in Painful Diabetic Peripheral Neuropathy.
Slangen R; Faber CG; Schaper NC; Joosten EA; van Dongen RT; Kessels AG; van Kleef M; Dirksen CD
J Pain; 2017 Apr; 18(4):405-414. PubMed ID: 27965045
[TBL] [Abstract][Full Text] [Related]
20. Moisture status of the skin of the feet assessed by the visual test neuropad correlates with foot ulceration in diabetes.
Tentolouris N; Voulgari C; Liatis S; Kokkinos A; Eleftheriadou I; Makrilakis K; Marinou K; Katsilambros N
Diabetes Care; 2010 May; 33(5):1112-4. PubMed ID: 20150296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
